Harmony Biosciences to Participate in Upcoming Investor Conferences

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)-- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will attend the following upcoming investor conferences.

Leerink Partners Global Healthcare Conference

• Date: March 9, 2026
• Location: Miami, FL

UBS Biotech Summit

• Date: March 9, 2026
• Location: Miami, FL

Barclays 28th Annual Global Healthcare Conference

• Date: March 10, 2026
• Location: Miami, FL

About Harmony Biosciences

Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, Pa., we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit www.harmonybiosciences.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260304620056/en/

Harmony Biosciences Investor Contact:
Matthew Beck
917-415-1750
[email protected]

Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
[email protected]

Source: Harmony Biosciences Holdings, Inc.

You May Also Be Interested In

• Dorian LPG Ltd. Announces VLGC Newbuilding Contracts, Forward Chartering Estimates, and New Credit Facility
• Ethniki Insurance Priced Its Inaugural €200mn Tier 2 and Restricted Tier 1 Perpetual Bonds
• Aqara Showcases The New Smart Lighting Series and Immersive Smart Home Experience at IFA 2026